TAFRO syndrome with a fatal clinical course following BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccination: A case report
- 11 April 2022
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 28 (7) , 1008-1011
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment OpportunitiesInternational Journal of Molecular Sciences, 2021
- Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety dataVaccine, 2021
- Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman diseaseAmerican Journal of Hematology, 2020
- Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with Trichosporon asahii infection in the lungs and myocardial infarction: an autopsy case report and literature reviewRenal Replacement Therapy, 2018
- Capillary leak syndrome: etiologies, pathophysiology, and managementKidney International, 2017
- Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 versionInternational Journal of Hematology, 2016
- Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV‐8‐negative multicentric Castleman diseaseAmerican Journal of Hematology, 2015
- Castleman-Kojima Disease (TAFRO Syndrome) : A Novel Systemic Inflammatory Disease Characterized by a Constellation of Symptoms, Namely, Thrombocytopenia, Ascites (Anasarca), Microcytic Anemia, Myelofibrosis, Renal Dysfunction, and Organomegaly : A Status Report and Summary of Fukushima (6 June, 2012) and Nagoya Meetings (22 September, 2012)Journal of Clinical and Experimental Hematopathology, 2013
- [Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly].2010
- The ITP syndrome: pathogenic and clinical diversityBlood, 2009